16 July 2025
Hogan Lovells advises on HK$611 million IPO and Chapter 18A listing of Cloudbreak Pharma Inc.
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Sammy Li Lead | Hogan Lovells | Partner | corporate | Hong Kong |
| Samson Suen | Hogan Lovells | Counsel | Not stated | Not stated |
| Tiffany Lam | Hogan Lovells | Senior associate | Not stated | Not stated |
| Vivian Siu | Hogan Lovells | Other | Not stated | Not stated |
| Richard Aftanas | Hogan Lovells | Partner | capital markets | New York |
| David Wallace | Hogan Lovells | Senior associate | Not stated | Not stated |
| Sophie Beutel | Hogan Lovells | Senior associate | Not stated | Not stated |
| Robert Church | Hogan Lovells | Partner | regulatory | Los Angeles |
| Eman Al-Hassan | Hogan Lovells | Senior associate | Not stated | Not stated |
| Will Tenbarge | Hogan Lovells | Associate | Not stated | Not stated |
Stated terms
- Stated value
- HKD 611m (HK$611 million)
- What the figure measures
- Issue size
- Client
- Cloudbreak Pharma Inc.Issuer
- Counterparties
- CCB International Capital Limited (Other)
Huatai Financial Holdings (Hong Kong) Limited (Other)